Arena Pharma Will Fail: Hedge Fund Poll

Hedge funds think Arena Pharmaceuticals will fail. That’s the consensus opinion emerging from an informal email poll taken last week, which asked healthcare buy-side investors, mostly biotech-focused hedge funds, to handicap the Sept. 16 FDA advisory panel that will review Arena’s obesity drug lorcaserin.
The Street